Trump threatens 200% tariffs on pharmaceuticals, impacting national security

President Donald Trump threatened to impose up to 200% tariffs on imported pharmaceuticals during a Cabinet meeting, giving drugmakers about a year to comply. The proposed tariffs, part of a Section 232 investigation, could impact national security. Pharmaceutical stocks remained stable despite concerns about increased costs and disrupted drug supply chains. Trump aims to incentivize U.S. drug manufacturing.

Read more at CNBC: Trump threatens pharmaceutical tariffs of 200%